Form 4: GoodRx Chief Accounting Officer Reports Routine Stock Transactions Following RSU Vesting

GoodRx Holdings, Inc.'s Chief Accounting Officer, Romin Nabiey, reported the acquisition of Class A Common Stock through the vesting and conversion of Restricted Stock Units (RSUs), alongside the disposition of shares to cover tax obligations.

Summary

• Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc. (GDRX), reported transactions on June 8, 2025, involving the company's Class A Common Stock.
• Nabiey acquired a total of 12,433 shares of Class A Common Stock through the exercise/conversion of Restricted Stock Units (RSUs) (10,201 shares and 2,232 shares).
• Concurrently, 4,449 shares were disposed of at a price of $4.08 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Romin Nabiey beneficially owns 126,075 shares of Class A Common Stock directly.
• Additionally, Nabiey holds 51,004 and 24,555 Restricted Stock Units, respectively, which represent contingent rights to receive Class A Common Stock upon future vesting.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine insider transaction related to equity compensation, not indicative of discretionary buying or selling based on market outlook.

Positives

• The vesting of Restricted Stock Units indicates continued equity accumulation for a key executive, aligning management's interests with shareholders.
• The transactions are part of a pre-established equity compensation plan, reflecting a routine and expected event for executives.

Negatives

• A portion of the acquired shares were immediately sold to cover tax liabilities, which is a common practice but results in a reduction of the net shares retained by the executive.

Future Outlook

The document indicates future vesting installments for the remaining Restricted Stock Units held by the reporting person, suggesting continued equity compensation over time.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transactions, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape for the healthcare technology sector.

Stakeholder Impact

• Shareholders: The report provides transparency into executive compensation and stock ownership, which is a standard governance practice. The net increase in shares held by the executive aligns their interests with shareholders.
• Employees: The RSU vesting demonstrates the company's ongoing equity compensation practices for its executives.

Next Steps

• Future quarterly vesting installments of the remaining 51,004 and 24,555 Restricted Stock Units held by Romin Nabiey.

Key Dates

Keywords

GoodRx Holdings, GDRX, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Ownership, Chief Accounting Officer